Looking forward to when the idiot shorts and pumpers are gone.
The worst is the topo54 clown. It isn't a 5 patient study you moron. SNTA reported 15 patients as part of the material event to illustrate that Enchant-1 met a pre-specified hurdle so is moving forward with the trial. SNTA reported 4 objective response some out of 15 in short term treated first line breast cancer patients. That is all, well that and the study is moving forward. You can say that the threshold was too low, but if so, why not provide the comparative data for FDA approved treatments for first line HER+ and first line TNBC?
Yes lots of data to still be collected, but stop acting as if SNTA is lying or attempting to characterize the data as statistically significant. The only one lying is you topo54 with your repeated "5 patient study" non-sense.
The more interesting data will come from the Ganetespib + Paclitaxel arm later this fall. Here is some realistic speculation. SNTA will be issuing a new stock offering to raise cash in the next two months or so.
Of course you know that the statistical significance of this study is ...???? Could you tell us? Yes - they lied because they withhold the numbers. They found a clown ( paid) to say that the study is "great".
What I say is that the jump is not at all justified, the company is bankrupt and they are FAR away of any money in. I did a study too - I had 2 patients - onw had tap water and the other one soda. The one with soda lived more that the one with water. Therefore SODA is great - 50% better survival, You got it clown?